Target Healthcare REIT (LON:THRL) Hits New 12-Month High – Still a Buy?

Target Healthcare REIT (LON:THRL) shares hit a new 52-week high on Wednesday . The company traded as high as GBX 108.80 and last traded at GBX 105.80, with a volume of 963337 shares changing hands. The stock had previously closed at GBX 106.60.

Analyst Ratings Changes

Separately, Jefferies Financial Group upped their target price on Target Healthcare REIT from GBX 99 to GBX 101 and gave the company a “buy” rating in a research report on Tuesday, October 28th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of GBX 101.

Target Healthcare REIT Price Performance

The firm has a market capitalization of £657.45 million, a PE ratio of 10.81, a P/E/G ratio of 1.48 and a beta of 0.44. The firm’s fifty day moving average price is GBX 102.23 and its 200 day moving average price is GBX 97.87. The company has a current ratio of 7.20, a quick ratio of 1.52 and a debt-to-equity ratio of 34.92.

Target Healthcare REIT Company Profile

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.